Yahoo
NYSE - Delayed Quote USD

Covista Inc. (CVSA)

126.50 -2.76 (-2.14%)
At close: October 28 at 4:00:02 PM EDT
126.45 -0.05 (-0.04%)
Pre-Market: 4:23:03 AM EDT
CVSA Q1 2027 earnings call
Today at 5 PM EDT
Chart Range Bar
Loading chart for CVSA
  • Previous Close 129.26
  • Open 130.25
  • Bid --
  • Ask 201.59 x 10000
  • Day's Range 124.72 - 130.74
  • 52 Week Range 86.97 - 152.12
  • Volume 326,673
  • Avg. Volume 335,309
  • Market Cap (intraday) 4.283B
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) 16.54
  • EPS (TTM) 7.65
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 158.75
  • Zacks Rating Neutral

Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary. The company provides degree programs, including bachelor's, master's, and doctoral degrees; and online certificate programs for nursing, health professions, medical, and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice. It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.

www.covista.com

4,736

Full Time Employees

June 30

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CVSA
22.26%
S&P 500 (^GSPC)
13.13%

1-Year Return

CVSA
17.85%
S&P 500 (^GSPC)
12.38%

3-Year Return

CVSA
153.10%
S&P 500 (^GSPC)
88.08%

5-Year Return

CVSA
232.63%
S&P 500 (^GSPC)
68.48%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 501.38M
Earnings 71.72M
Profit Margin 14.30%

Q1

FY26

Q2

FY26

Q3

FY26

Q4

FY26

0
100M
200M
300M
400M
500M
10.0%
12.0%
14.0%

Analyst Insights

View More

Analyst Price Targets

140.00
158.75 Average
126.50 Current
175.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/5/2026
Analyst BMO Capital
Rating Action Maintains
Rating Outperform
Price Action Lowers
Price Target 148 -> 145

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    12.87%

  • Return on Assets (ttm)

    8.45%

  • Return on Equity (ttm)

    18.57%

  • Revenue (ttm)

    1.95B

  • Net Income Avi to Common (ttm)

    267.38M

  • Diluted EPS (ttm)

    7.65

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    406.32M

  • Total Debt/Equity (mrq)

    62.61%

  • Levered Free Cash Flow (ttm)

    323.94M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: